Related Experiment Videos
CD34 expression in de novo acute myeloid leukaemia
British Journal of Haematology
|November 1, 1993
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Chemotherapy for patients with circulating tumour DNA-positive, stage II colon cancer (CIRCULATE)-an AIO/ABCSG trial.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Evaluation of platelet adhesion and activation on polymers: Round-robin study to assess inter-center variability.
Colloids and surfaces. B, Biointerfaces·2017
Right heart ischemia in cases of sepsis.
Forensic science international·2016
Functional assessment of inherited myeloid neoplasm-associated SAMD9L germline variants via Monoallelic CRISPR modelling.
British journal of haematology·2026
Sickle cell disease and commercial aviation. A retrospective analysis of in-flight and pre-flight medical events.
British journal of haematology·2026
LTB-TREAT: A validated international prognostic model for time to treatment in low tumour burden follicular lymphoma.
British journal of haematology·2026
Autoimmune neutropenia in children: Test cells versus beads and a role for pro-LL-37 and absolute neutrophil count.
British journal of haematology·2026
Real-world outcomes of ide-cel and cilta-cel in relapsed/refractory multiple myeloma: A nationwide, retrospective analysis in Austria.
British journal of haematology·2026
Transcatheter Aortic Valve Replacement or Medical Treatment for Paradoxical Low-Flow, Low-Gradient Aortic Valve Stenosis: REBOOT-PARADOX.
Journal of the American College of Cardiology·2026
A multicenter prospective observational cohort study to improve diagnostic yield and clinical management of persons with a Bleeding Disorder of Unknown Cause (BDUC-iN study protocol).
Research and practice in thrombosis and haemostasis·2026
Avatrombopag in thrombopoietin receptor agonist-naïve patients with immune thrombocytopenia: real-world treatment patterns and clinical outcomes from the REAL-AVA 3.0 study.
Research and practice in thrombosis and haemostasis·2026
Retraction: Targeted plasmalogen supplementation: effects on blood plasmalogens, oxidative stress biomarkers, cognition, and mobility in cognitively impaired persons.
Frontiers in cell and developmental biology·2026